Richard A. Paulson, President and CEO at Karyopharm Therapeutics Inc. (KPTI), sold 3,622 shares at $1.32 ($5K) on 2023-09-05, disclosed to the SEC on 2023-09-06.
Open-market sale of $5k KPTI by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.32 | 64 | $84 | 1.8% |
| 2 | $1.33 | 3,558 | $5K | 98.2% |
| Total | $1.33 avg | 3,622 | $5K | 100% |
| Filing → |
| KPTI | SELL | 2025-09-16 | $8K | — | Filing → |
| KPTI | SELL | 2025-05-07 | $2K | — | Filing → |
| KPTI | SELL | 2025-04-07 | $916 | — | Filing → |